SCHEMBL9007181

SCHEMBL9007181

Cc1cc(CO)c(C[Si](C)(C)C)c(C)c1O

nearest known ligand 0.42

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
SHBG P04278 1/20 0.42
KDM4E B2RXH2 3/20 0.37
ALDH1A1 P00352 3/20 0.37
HPGD P15428 2/20 0.37
HSD17B10 Q99714 1/20 0.37
LMNA P02545 3/20 0.34
MAOA P21397 1/20 0.33
PDXK O00764 3/20 0.33
CA1 P00915 1/20 0.31
CA2 P00918 1/20 0.31
GAA P10253 1/20 0.31
MAPT P10636 1/20 0.31
ESR1 P03372 1/20 0.31
MEN1 O00255 1/20 0.30
KMT2A Q03164 1/20 0.30
AOX1 Q06278 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5608947 0.74 SHBG (0.52) SHBGKDM4EALDH1A1HPGDHSD17B10
SCHEMBL27984345 0.72 SHBG (0.50) SHBGKDM4EALDH1A1HPGDHSD17B10
SCHEMBL7522113 0.71 SHBG (0.48) SHBGKDM4EALDH1A1HPGDHSD17B10
SCHEMBL7526681 0.70 CA1 (0.33) SHBGKDM4EALDH1A1LMNACA1
SCHEMBL28585139 0.70 SHBG (0.42) SHBGKDM4EALDH1A1HPGDHSD17B10
SCHEMBL13866611 0.69 KDM4E (0.48) SHBGKDM4EALDH1A1HPGDHSD17B10
SCHEMBL14283816 0.69 SHBG (0.45) SHBGKDM4EALDH1A1HPGDHSD17B10
SCHEMBL5680646 0.68 SELL (0.34) KDM4EALDH1A1HPGDHSD17B10LMNA
SCHEMBL25328340 0.67 ESR1 (0.39) SHBGKDM4EMAOACA1CA2
SCHEMBL2219441 0.67 SHBG (0.48) SHBGKDM4EALDH1A1HPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0732928-A1 METHOD OF LOWERING SERUM CHOLESTEROL LEVELS WITH 2,6-DI-ALKYL-4-SILYL-PHENOLS MERRELL PHARMACEUTICALS INC. (US) 1996-09-25 EP disclosed
WO-1995015760-A1 METHOD OF LOWERING SERUM CHOLESTEROL LEVELS WITH 2,6-DI-ALKYL-4-SILYL-PHENOLS MERRELL PHARMACEUTICALS INC. (US) 1995-06-15 WO disclosed